Диссертация (Моделирование структуры липополисахаридов и их роли в процессе патологического свертывания крови), страница 36

2. — P. 554–559.[129] Derhaschnig, U. Blockade of GPIIb/IIIa by eptifibatide and tirofiban does not alter tissuefactor induced thrombin generation in human endotoxemia / U. Derhaschnig, C. Pachinger,I. Schweeger-Exeli, et al. // Thromb. Haemost. — 2003. — Vol. 90. — P. 1054–1061.182[130] Aras, O. Induction of microparticle- and cell-associated intravascular tissue factor in humanendotoxemia / O. Aras, A.

Shet, R. R. Bach, et al. // Blood. — 2004. — Vol. 103. —P. 4545–4553.[131] Warr, T. Disseminated intravascular coagulation in rabbits induced by administration ofendotoxin or tissue factor: Effect of anti-tissue factor antibodies and measurement of plasmaextrinsic pathway inhibitor activity / T. Warr, L. Rao, S. Rapaport // Blood. — 1990. —Vol. 75. — P. 1481–1489.[132] Taylor, F. B. Jr. Lethal E.

coli septic shock is prevented by blocking tissue factor withmonoclonal antibody / F. B. Jr. Taylor, A. Chang, W. Ruf, et al. // Circ Shock. — 1991.— Vol. 33. — P. 127–134.[133] Levi, M. Inhibition of endotoxin-induced activation of coagulation and fibrinolysis by pentoxifylline or by a monoclonal anti-tissue factor antibody in chimpanzees / M.

Levi, H. ten Cate,K. A. Bauer, et al. // J. Clin. Invest. — 1994. — Vol. 93. — P. 114–120.[134] Taylor, F. B. Active site inhibited factor VIIa (DEGR VIIa) attenuates the coagulant andinterleukin-6 and -8, but not tumor necrosis factor, responses of the baboon to LD100Escherichia coli / F. B. Taylor, A. C. Chang, G. Peer, et al. // Blood. — 1998. — Vol. 91.— P. 1609–1615.[135] Creasey, A. A. Tissue factor pathway inhibitor reduces mortality from Escherichia coli septicshock / A. A. Creasey, A.

C. Chang, L. Feigen, et al. // J. Clin. Invest. — 1993. — Vol. 91.— P. 2850–2860.[136] Pawlinski, R. Role of tissue factor and protease-activated receptors in a mouse model ofendotoxemia / R. Pawlinski, B. Pedersen, G. Schabbauer, et al. // Blood. — 2004.

— Vol.103. — P. 1342–1347.[137] Xu, H. A coagulation factor VII deficiency protects against acute inflammatory responsesin mice / H. Xu, V. A. Ploplis, F. J. Castellino // J. Pathol. — 2006. — Vol. 210. —P. 488–496.[138] Egorina, E. M. Intracellular and surface distribution of monocyte tissue factor: application tointersubject variability. / E. M. Egorina, M. A. Sovershaev, G. Bjorkoy, et al.

// Arterioscler.Thromb. Vasc. Biol. — 2005. — Vol. 25. — P. 1493–1498.183[139] Rivers, R. P. The endotoxin-induced coagulant activity of human monocytes / R. P. Rivers,W. E. Hathaway, W. L. Weston // Br. J. Haematol. — 1975. — Vol. 30, no. 3. —P. 311–316.[140] Gregory, S. A. Regulation of tissue factor gene expression in the monocyte procoagulantresponse to endotoxin / S. A.

Gregory, J. H. Morrissey, T. S. Edgington // Mol. Cell. Biol.— 1989. — Vol. 9, no. 6. — P. 2752–2755.[141] Drake, T. A. Functional tissue factor is entirely cell surface expressed on lipopolysaccharidestimulated human blood monocytes and a constitutively tissue factor-producing neoplasticcell line / T.

A. Drake, W. Ruf, J. H. Morrissey, T. S. Edgington // J. Cell. Biol. — 1989.— Vol. 109, no. 1. — P. 389–395.[142] Meszaros, K. Monocyte tissue factor induction by lipopolysaccharide (LPS): dependence on LPS-binding protein and CD14, and inhibition by a recombinant fragment ofbacterial/permeability-increasing protein / K.

Meszaros, S. Aberle, R. Dedrick, et al. //Blood. — 1994. — Vol. 83, no. 9. — P. 2516–2525.[143] Suzuki, T. Comprehensive gene expression profile of LPS-stimulated human monocytes bySAGE / T. Suzuki, S. Hashimoto, N. Toyoda, et al. // Blood. — 2000. — Vol. 96, no. 7.— P. 2584–2591.[144] Aird, W. C. The role of the endothelium in severe sepsis and multiple organ dysfunctionsyndrome / W.

C. Aird // Sepsis. — 2003. — Vol. 101, no. 10. — P. 3765–3777.[145] Moore, K. L. Endotoxin enhances tissue factor and suppresses thrombomodulin expression of human vascular endothelium in vitro / K. L. Moore, S. P. Andreoli, N. L. Esmon,N. U. Bang // J. Clin. Invest. — 1987. — Vol. 79, no. 1.

— P. 124–130.[146] Crossman, D. C. The regulation of tissue factor mRNA in human endothelial cells in responseto endotoxin or phorbol ester / D. C. Crossman, D. P. Carr, E. G. Tuddenham, et al. // J.Biol. Chem. — 1990. — Vol. 265, no. 17. — P. 9782–9787.[147] Bannerman, D. D. Integrity and survival signaling events through caspase cleavage of adherens junction proteins / D. D. Bannerman, M. Sathyamoorthy, S. E. Goldblum // J. Biol.Chem. — 1998. — Vol. 273, no. 52.

— P. 35371–35380.184[148] Haimovitz-Friedman, A. Lipopolysaccharide Induces disseminated endothelial apoptosis requiring ceramide generation / A. Haimovitz-Friedman, C. Cordon-Cardo, S. Bayoumy,et al. // J. Exp. Med. — 1997. — Vol. 186, no. 11. — P. 1831.[149] Owens, A. P. 3rd. Microparticles in hemostasis and thrombosis / A. P. 3rd Owens, N. Mackman // Circ. Res.

— 2011. — Vol. 108. — P. 1284–1297.[150] Morel, O. Procoagulant microparticles: disrupting the vascular homeostasis equation? /O. Morel, F. Toti, B. Hugel, et al. // Arterioscler. Thromb. Vasc. Biol. — 2006. —Vol. 26. — P. 2594–2604.[151] Falati, S. Accumulation of tissue factor into developing thrombi in vivo is dependent uponmicroparticle P-selectin glycoprotein ligand 1 and platelet P-selectin / S. Falati, Q. Liu,P. Gross, et al. // J. Exp. Med. — 2003.

— Vol. 197. — P. 1585–1598.[152] Mayr, F. B. Racial differences in endotoxin-induced tissue factor-triggered coagulation /F. B. Mayr, A. O. Spiel, J. M. Leitner, et al. // J. Thromb. Haemost. — 2009. — Vol. 7.— P. 634–640.[153] Челушкин, М. А. Активация контактного пути свертывания крови на циркулирующихмикровезкулах может объяснить гиперкоагуляцию при разбавлении плазмы / М. А.

Челушкин, М. А. Пантелеев, А. Н. Свешникова // Биол. мембр. — 2017. — Т. 34, № 2. —С. 126–141.[154] Lipets, E. Circulating contact-pathway-activating microparticles together with factors IXaand XIa induce spontaneous clotting in plasma of hematology and cardiologic patients /E. Lipets, O. Vlasova, E. Urnova, et al. // PLoS ONE. — 2014. — Vol. 9, no. 1. —P. e87692.[155] DeLa Cadena, R.

A. Activation of the kallikrein-kinin system after endotoxin administrationto normal human volunteers / R. A. DeLa Cadena, A. F. Suffredini, J. D. Page, et al. //Blood. — 1993. — Vol. 81, no. 12. — P. 3313–3317.[156] Roeise, O. Dose dependence of endotoxin-induced activation of the plasma contact system:an in vitro study / O. Roeise, B. N. Bouma, J. O.

Stadaas, A. O. Aasen // Circ. Shock. —1988. — Vol. 26. — P. 419–430.185[157] Lerner, R. G. Endotoxin-induced intravascular clotting:the need for granulocytes /R. G. Lerner, S. I. Rapaport, J. M. Spitzer // Thromb. Diath. Haemorrh. — 1968.— Vol. 20. — P. 430–443.[158] Gallimore, M. J. Falls in plasma levels of prekallikrein, high molecular weight kininogen, andkallikrein inhibitors during lethal endotoxin shock in dogs / M. J. Gallimore, A. O. Aasen,K. H.

Lyngaas, et al. // Thromb. Res. — 1978. — Vol. 12. — P. 307–318.[159] Minnema, M. C. Activation of clotting factor XI without detectable contact activation inexperimental human endotoxemia / M. C. Minnema, D. Pajkrt, W. A. Wuillemin, et al. //Blood. — 1998. — Vol.

92. — P. 3294–3301.[160] van Deventer, S. Experimental endotoxemia in humans: analysis of cytokine release andcoagulation, fibrinolytic, and complement pathways / S. van Deventer, H. Buller, J. ten Cate,et al. // Blood. — 1990. — Vol. 76. — P. 2520–2526.[161] Frick, I.-M. The contact system–a novel branch of innate immunity generating antibacterialpeptides. / I.-M. Frick, P. Akesson, H. Herwald, et al.

// EMBO J. — 2006. — Vol. 25,no. 23. — P. 5569–5578.[162] Herwald, H. Activation of the contact-phase system on bacterial surfaces — a clue to seriouscomplications in infectious diseases / H. Herwald, M. Mörgelin, A. Olsén, et al. // Naturemedicine. — 1998. — Vol. 4, no. 3. — P. 298–302.[163] Oursel, D. Lipid composition of membranes of Escherichia coli by liquid chromatography/tandem mass spectrometry using negative electrospray ionization / D. Oursel,C. Loutelier-Bourhis, N. Orange, et al. // Rapid Commun.

Mass Spectrom. — 2007.— Vol. 21. — P. 1721–1728.[164] Nikaido, H. Molecular basis of bacterial outer membrane permeability revisited /H. Nikaido // Microbiol. Mol. Biol. Rev. — 2003. — Vol. 67, no. 4. — P. 593–656.[165] Silipo, A. Lipid A structure / A. Silipo, A. Molinaro // Bacterial Lipopolysaccharides / Ed.by Y.A. Knirel, Y.A. Valvano. — : Springer Vienna, 2011. — P. 1–20.[166] Silipo, A. The diversity of the core oligosaccharide in lipopolysaccharides / A. Silipo, A. Molinaro // Subcell. Biochem. — 2010. — Vol. 53. — P. 69–99.[167] Raetz, R.